Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis

Benjamin Turner, Bruce A. C. Cree, Ludwig Kappos, Xavier Montalban, Caroline Papeix, Jerry S. Wolinsky, Regine Buffels, Damian Fiore, Hideki Garren, Jian Han, Stephen L. Hauser

Open source

DOI: 10.1007/s00415-019-09248-6
Published: 2019-02-28
Container: Journal of Neurology
Publisher: Springer Science and Business Media LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1007/s00415-019-09248-6,
  title = {Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis},
  author = {Benjamin Turner and Bruce A. C. Cree and Ludwig Kappos and Xavier Montalban and Caroline Papeix and Jerry S. Wolinsky and Regine Buffels and Damian Fiore and Hideki Garren and Jian Han and Stephen L. Hauser},
  year = {2019},
  journal = {Journal of Neurology},
  doi = {10.1007/s00415-019-09248-6},
  url = {https://doi.org/10.1007/s00415-019-09248-6}
}

RIS

TY  - JOUR
TI  - Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis
AU  - Benjamin Turner
AU  - Bruce A. C. Cree
AU  - Ludwig Kappos
AU  - Xavier Montalban
AU  - Caroline Papeix
AU  - Jerry S. Wolinsky
AU  - Regine Buffels
AU  - Damian Fiore
AU  - Hideki Garren
AU  - Jian Han
AU  - Stephen L. Hauser
PY  - 2019
JO  - Journal of Neurology
DO  - 10.1007/s00415-019-09248-6
UR  - https://doi.org/10.1007/s00415-019-09248-6
ER  -

APA

Turner, B., Cree, B. A. C., Kappos, L., Montalban, X., Papeix, C., Wolinsky, J. S., Buffels, R., Fiore, D., Garren, H., Han, J., & Hauser, S. L. (2019). Ocrelizumab efficacy in subgroups of patients with relapsing multiple sclerosis. Journal of Neurology. https://doi.org/10.1007/s00415-019-09248-6

Source records

crossref · retrieved 2026-09-25T20:27:29.568Z